The report covers the period 2019/2020 and highlights the company's commitment to sustainable impact across various areas. The report highlights the advancement of two SARS-CoV-2/COVID-19 vaccine candidates, the prequalification of ERVEBO (Ebola Zaire Vaccine) by the WHO and FDA, and the company's commitment to supporting small- and minority-owned businesses. The report also focuses on diversity and inclusion, and the company's progress in reducing their environmental footprint through initiatives such as reducing energy demand and purchasing renewable energy.
Issuing Company Merck and Co., Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 2.25 MB
No. of Pages 96 pages
Reporting period2019/2020
Report EditionUnknown
Assurance Provider WSP
Reporting Standards GRI; SASB; UNSDG
Materiality Assessmenttrue
